Paul Kettle

420 total citations
26 papers, 274 citations indexed

About

Paul Kettle is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Paul Kettle has authored 26 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Paul Kettle's work include Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Paul Kettle is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Paul Kettle collaborates with scholars based in United Kingdom, Ireland and United States. Paul Kettle's co-authors include H. Denis Alexander, Mary Drake, E. E. Mayne, Mark Catherwood, Christina Donatti, Martin J.S. Dyer, Stephen A. Johnson, Ruth Pettengell, M. Susan Walker and C Poynton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Paul Kettle

24 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Kettle United Kingdom 10 108 88 60 60 57 26 274
Masanobu Morioka Japan 11 73 0.7× 53 0.6× 44 0.7× 129 2.1× 47 0.8× 64 329
Lawrence R. Johnson United States 6 121 1.1× 86 1.0× 43 0.7× 74 1.2× 51 0.9× 8 318
Julian Cooney Australia 10 125 1.2× 45 0.5× 96 1.6× 134 2.2× 44 0.8× 30 317
Bruce Greig United States 7 82 0.8× 104 1.2× 74 1.2× 151 2.5× 83 1.5× 10 319
Emre Tekgündüz Türkiye 10 81 0.8× 31 0.4× 42 0.7× 139 2.3× 33 0.6× 58 316
Sheryl L. Asplund United States 12 98 0.9× 155 1.8× 115 1.9× 88 1.5× 32 0.6× 15 329
Seçkin Çağırgan Türkiye 9 67 0.6× 35 0.4× 58 1.0× 187 3.1× 56 1.0× 45 329
Maria-Elena Cabezudo Spain 11 93 0.9× 72 0.8× 88 1.5× 173 2.9× 51 0.9× 23 337
Mohamed Samra Egypt 10 84 0.8× 30 0.3× 53 0.9× 109 1.8× 67 1.2× 44 296
Jeremy Ramdial United States 10 129 1.2× 86 1.0× 42 0.7× 121 2.0× 39 0.7× 62 310

Countries citing papers authored by Paul Kettle

Since Specialization
Citations

This map shows the geographic impact of Paul Kettle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kettle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kettle more than expected).

Fields of papers citing papers by Paul Kettle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kettle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kettle. The network helps show where Paul Kettle may publish in the future.

Co-authorship network of co-authors of Paul Kettle

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kettle. A scholar is included among the top collaborators of Paul Kettle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kettle. Paul Kettle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drake, Mary, Paul Kettle, Michael O’Dwyer, et al.. (2021). How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma. SHILAP Revista de lepidopterología. 3(1). 27–27. 1 indexed citations
2.
Bleakley, Chris J., et al.. (2017). Ultrasonic hand gesture recognition for mobile devices. Journal on Multimodal User Interfaces. 12(1). 31–39. 15 indexed citations
3.
Catherwood, Mark, et al.. (2012). Neither P‐gp SNP variants, P‐gp expression nor functional P‐gp activity predicts MDR in a preliminary study of plasma cell myeloma. Cytometry Part B Clinical Cytometry. 82B(4). 229–237. 5 indexed citations
4.
Drake, Mary, Paul Kettle, Nick Orr, et al.. (2011). Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. Leukemia Research. 35(11). 1457–1463. 15 indexed citations
5.
Allen, Patrick B., Paul Kettle, & Inder Mainie. (2010). Massive Tracheal-Esophageal Fistula Secondary to Lymphoma Treated With an Esophageal Stent. Clinical Gastroenterology and Hepatology. 9(6). e52–e53.
6.
Hoeritzauer, Ingrid, et al.. (2009). Bronchial associated lymphoid tissue (BALT) lymphoma presenting as chronic lung sepsis. BMJ Case Reports. 2009. bcr0320091716–bcr0320091716.
7.
Catherwood, Mark, Nick Orr, Leeona Galligan, et al.. (2009). ABCB1 (MDR1)rs1045642 is associated with increased overall survival in plasma cell myeloma. Leukemia & lymphoma. 50(4). 566–570. 23 indexed citations
8.
Oakervee, Heather, Paul Kettle, Gary Cook, et al.. (2009). A161 The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. Clinical Lymphoma & Myeloma. 9. S27–S27. 1 indexed citations
9.
Morris, T. C. M., Paul Kettle, Mary Drake, et al.. (2008). Clarithromycin with low dose dexamethasone and thalidomide is effective therapy in relapsed/refractory myeloma. British Journal of Haematology. 143(3). 349–354. 19 indexed citations
10.
Pettengell, Ruth, Christina Donatti, Peter Hoskin, et al.. (2007). The impact of follicular lymphoma on health-related quality of life. Annals of Oncology. 19(3). 570–576. 72 indexed citations
11.
Percy, Melanie J., Richard van Wijk, G. Savage, et al.. (2007). Pyruvate kinase deficient hemolytic anemia in the Northern Irish population. Blood Cells Molecules and Diseases. 39(2). 189–194. 6 indexed citations
12.
Morris, Curly, Paul Kettle, Mary Drake, et al.. (2007). PAD Given at Relapse Is More Effective Than VAD Given as Induction Therapy - Results of a Phase II Study.. Blood. 110(11). 2724–2724. 1 indexed citations
13.
Matthews, Christine, Mark Catherwood, T. C. M. Morris, et al.. (2006). Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression. European Journal Of Haematology. 77(4). 309–317. 23 indexed citations
14.
15.
Xu, Jiru, Paul J. Rooney, B. Cherie Millar, et al.. (2005). Central line-related bacteremia due toRoseomonas mucosain a patient with diffuse large B-cell non-Hodgkin's lymphoma. Leukemia & lymphoma. 46(4). 611–614. 17 indexed citations
16.
Kettle, Paul, et al.. (2003). Quantitation of Monoclonal Plasma Cells in Bone Marrow Biopsies in Plasma Cell Dyscrasia. Analytical Cellular Pathology. 25(4). 167–171. 4 indexed citations
17.
Alexander, H. Denis, et al.. (2002). Tetrasomy 13 as the sole cytogenetic abnormality in acute myeloid leukemia M1 without maturation. Cancer Genetics and Cytogenetics. 135(2). 192–195. 1 indexed citations
18.
Kettle, Paul & Curly Morris. (1994). Late relapse in IgD myeloma: value of immunohistochemistry in trephine biopsy specimens.. Journal of Clinical Pathology. 47(8). 773–774. 2 indexed citations
19.
Kettle, Paul, et al.. (1991). Pseudothrombocytopenia--a cautionary tale.. PubMed. 60(2). 254–6. 1 indexed citations
20.
Kettle, Paul, Curly Morris, H. Denis Alexander, et al.. (1990). Tartrate resistant acid phosphatase positive splenic lymphoma: a relatively benign condition occurring in a time-space cluster?. Journal of Clinical Pathology. 43(9). 714–718. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanobu Morioka Breakdown of academic impact, for papers by Lawrence R. Johnson Breakdown of academic impact, for papers by Julian Cooney Breakdown of academic impact, for papers by Bruce Greig Breakdown of academic impact, for papers by Emre Tekgündüz Breakdown of academic impact, for papers by Sheryl L. Asplund Breakdown of academic impact, for papers by Seçkin Çağırgan Breakdown of academic impact, for papers by Maria-Elena Cabezudo Breakdown of academic impact, for papers by Mohamed Samra Breakdown of academic impact, for papers by Jeremy Ramdial
Rankless by CCL
2026